Abstract
A series of novel 3'-amido-3'-deoxy-N(6)-(1-naphthylmethyl)adenosines was synthesized applying a polymer-assisted solution phase (PASP) protocol and was tested for anti-malarial activity versus the Dd2 strain of Plasmodium falciparum. Further, this series and 62 adenosine derivatives were analyzed regarding 1-deoxy-d-xylulose 5-phosphate (DOXP) reductoisomerase inhibition. Biological evaluations revealed that the investigated 3',N(6)-disubstituted adenosine derivatives displayed moderate but significant activity against the P. falciparum parasite in the low-micromolar range. On the molecular level, DOXP reductoisomerase utilizing an adenosyl-containing substrate was identified as a promising metabolic target for ligands of adenosine binding motifs.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adenosine / chemical synthesis
-
Adenosine / chemistry*
-
Adenosine / pharmacology*
-
Aldose-Ketose Isomerases / antagonists & inhibitors
-
Aldose-Ketose Isomerases / metabolism
-
Animals
-
Antimalarials / chemical synthesis
-
Antimalarials / chemistry*
-
Antimalarials / pharmacology*
-
Enzyme Inhibitors / chemical synthesis
-
Enzyme Inhibitors / chemistry
-
Enzyme Inhibitors / pharmacology
-
Inhibitory Concentration 50
-
Molecular Structure
-
Multienzyme Complexes / antagonists & inhibitors
-
Multienzyme Complexes / metabolism
-
Oxidoreductases / antagonists & inhibitors
-
Oxidoreductases / metabolism
-
Plasmodium falciparum / drug effects
-
Plasmodium falciparum / enzymology
Substances
-
Antimalarials
-
Enzyme Inhibitors
-
Multienzyme Complexes
-
Oxidoreductases
-
1-deoxy-D-xylulose 5-phosphate reductoisomerase
-
Aldose-Ketose Isomerases
-
Adenosine